A fulminant colitis index greater or equal to 8 is not predictive of colectomy risk in infliximab-treated moderate-to-severe ulcerative colitis attacks. [electronic resource]
Producer: 20110404Description: 612-7 p. digitalISSN:- 0399-8320
- Adolescent
- Adult
- Aged
- Anti-Inflammatory Agents -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Colectomy -- methods
- Colitis, Ulcerative -- diagnosis
- Drug Therapy, Combination
- Female
- Gastrointestinal Agents -- therapeutic use
- Glucocorticoids -- therapeutic use
- Humans
- Infliximab
- Intestinal Mucosa -- pathology
- Male
- Middle Aged
- Predictive Value of Tests
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Sensitivity and Specificity
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.